Serina Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
AMEX
Juvenescence Limited and its subsidiaries now beneficially own approximately 27.3% of Serina Therapeutics, Inc. following a recent private placement.